International Service for the Acquisition of Agri-biotech Applications

International Service for the Acquisition of Agri-biotech Applications
Name	International Service for the Acquisition of Agri-biotech Applications
Abbreviation	ISAAA
Formation	1990
Headquarters	Ithaca, New York
Type	Non-profit organization
Purpose	Technology transfer, capacity building, biotechnology dissemination
Region served	Global, with emphasis on Asia, Africa, Latin America
Leader title	Director

International Service for the Acquisition of Agri-biotech Applications The International Service for the Acquisition of Agri-biotech Applications is a non-profit organization focused on facilitating access to agricultural biotechnology for developing-country stakeholders. It operates at the intersection of technology transfer, capacity building, and policy outreach, engaging with institutions across Asia, Africa, and Latin America to promote adoption of transgenic crops, biosafety frameworks, and biotechnology communication. The organization is known for producing annual reports and briefing materials aimed at researchers, policymakers, and agribusiness actors.

Overview and Mission

The organization states a mission to bridge technological gaps between United States-based research institutions, Consultative Group on International Agricultural Research centers, and national research systems in countries such as India, China, Brazil, South Africa, and Philippines. Its activities emphasize collaboration with entities like University of California, Cornell University, International Rice Research Institute, CIMMYT, and AfricaRice to introduce traits developed through partnerships with companies such as Monsanto and Syngenta. The stated objectives include technology acquisition, knowledge dissemination, and capacity strengthening for regulatory processes aligned with instruments like the Cartagena Protocol on Biosafety and standards referenced by the World Trade Organization.

History and Development

Founded in 1990 during a period of rapid expansion in plant transformation research driven by groups including Kary Mullis-era biotechnology labs and corporate research divisions of Dow Chemical Company, the organization emerged amid discussions at forums such as Food and Agriculture Organization meetings and World Bank seminars on agricultural development. Early work linked to collaborations with scientists from institutions like Iowa State University, University of Missouri, and Cold Spring Harbor Laboratory. Over the 1990s and 2000s, it expanded programs in parallel with commercialization milestones like the approval of herbicide-tolerant soybean in Argentina and insect-resistant cotton in China. Key milestones include dissemination of information following approvals by regulatory bodies such as the United States Department of Agriculture and interactions at summits like the World Economic Forum.

Programs and Services

Programs have ranged from training workshops for researchers from Kenya, Nigeria, and Bangladesh to development of outreach materials for extension agents linked to organizations like International Fund for Agricultural Development and Bill & Melinda Gates Foundation initiatives. Services include technology evaluation, proficiency testing in molecular diagnostics performed in collaboration with laboratories at Johns Hopkins University and Michigan State University, and preparation of briefs on adoption metrics referenced by analysts at IFPRI and OECD. The organization has published a series of annual briefs and maps often cited in studies by authors affiliated with Harvard University, Stanford University, and London School of Economics analyzing adoption trajectories in regions like Sub-Saharan Africa and Southeast Asia.

Governance and Funding

Governance has involved a board comprised of figures drawn from academia, industry, and non-governmental organizations with past ties to institutions such as Rockefeller Foundation, Wellcome Trust, and corporate entities including BASF. Funding historically combined philanthropic grants from organizations like Gates Foundation with contracts and in-kind support linked to corporations and multilaterals including World Bank projects. Financial oversight and accountability have been discussed in forums such as Transparency International panels and audited in consultation with firms comparable to KPMG and PwC. Relationships with private-sector actors have influenced strategic priorities, prompting scrutiny by stakeholders associated with Greenpeace and Friends of the Earth.

Partnerships and Global Impact

The organization has partnered with national agricultural research systems including ICRISAT, Bangladesh Rice Research Institute, and Kenya Agricultural and Livestock Research Organization to facilitate field trials, seed dissemination, and regulatory capacity building. Collaboration with regional entities such as the African Union's agricultural initiatives and the Association of Southeast Asian Nations technical working groups expanded its footprint. Impact assessments cite increased adoption of biotech traits in countries like South Africa, Brazil, and Argentina, while policy dialogues influenced drafting of biosafety guidelines referenced by negotiators at UN Convention on Biological Diversity meetings. Publications from collaborators at University of Oxford and University of Cambridge have used the organization’s datasets to model economic impacts and yield differentials.

Criticism and Controversies

Critics from activist groups such as Greenpeace International and academics associated with People's Science Movement have raised concerns regarding perceived pro-industry bias and the implications of technology transfer linked to multinational firms like Bayer (following its acquisition of Monsanto). Debates have centered on intellectual property issues involving entities like Biological Resource Center-type institutions and enforcement under treaties resembling the TRIPS Agreement. Controversies have arisen around communication strategies during high-profile events such as protests in Philippines and debates at European Parliament committees addressing genetically modified organism approvals. Independent panels convened by organizations like Royal Society and commentators from The Lancet have called for greater transparency in funding disclosures and for more robust engagement with civil society networks including Oxfam and ActionAid.

Category:Agricultural biotechnology organizations